DoD can't continue to ignore this conflict of interest that arises when a company owns both a PBM and a pharmacy. That has ...

Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin. By Katie Thomas Consumers whose drug ...

There have been several recent efforts to crack down on pharmacy benefit managers, from bills in Congress to an investigation by the Federal Trade Commission. But the state of Arkansas has been the ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...